Correlation Between PsyBio Therapeutics and Vg Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Vg Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Vg Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and Vg Life Sciences, you can compare the effects of market volatilities on PsyBio Therapeutics and Vg Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Vg Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Vg Life.

Diversification Opportunities for PsyBio Therapeutics and Vg Life

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between PsyBio and VGLS is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Vg Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vg Life Sciences and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Vg Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vg Life Sciences has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Vg Life go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Vg Life

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to under-perform the Vg Life. But the pink sheet apears to be less risky and, when comparing its historical volatility, PsyBio Therapeutics Corp is 14.62 times less risky than Vg Life. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Vg Life Sciences is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Vg Life Sciences on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Vg Life Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

PsyBio Therapeutics Corp  vs.  Vg Life Sciences

 Performance 
       Timeline  
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Vg Life Sciences 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

PsyBio Therapeutics and Vg Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PsyBio Therapeutics and Vg Life

The main advantage of trading using opposite PsyBio Therapeutics and Vg Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Vg Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vg Life will offset losses from the drop in Vg Life's long position.
The idea behind PsyBio Therapeutics Corp and Vg Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk